Latest News

Pharmaceutical NPS drug approval bolsters Shire acquisition decision

NPS drug approval bolsters Shire acquisition decision

The FDA approved NPS Pharmaceuticals's rare-disease drug Friday. The company, which Shire shelled out $5.2 billion to buy, expects it to hit the market during the second-quarter.

Pharmaceutical Sanofi, Regeneron officially in PCSK9 race

Sanofi, Regeneron officially in PCSK9 race

The drugmakers have filed alirocumab with the FDA, closing the gap between its candidate and Amgen's evolucumab.

Pharmaceutical

Approval pits Novartis meningococcal vaccine against Pfizer shot

FDA has approved Novartis's Bexsero after approving Pfizer's Trumemba this past October.

Pharmaceutical

New cancer therapies raise new safety concerns

Two new classes of medicines have shown unparalleled efficacy in oncology, but there are growing concerns about the treatments' safety.

Pharmaceutical Five things for pharma marketers to know: Monday, January 26

Five things for pharma marketers to know: Monday, January 26

Actavis acquires Auden Mckenzie for $459 million; Sanofi/Regeneron's PCSK9 inhibitor could be first to market; Gilead strikes a deal for Harvoni and Sovaldi with four German health insurers.

Features Meg Columbia-Walsh, Founder & CEO, Inverse Mobile

Meg Columbia-Walsh, Founder & CEO, Inverse Mobile

Session: Inter-generational CEO Summit Panel

Features Josh Stein, CEO & Co-Founder, AdhereTech

Josh Stein, CEO & Co-Founder, AdhereTech

Session: Inter-generational CEO Summit Panel

Features Benjamin Wolin, Chief Executive Officer & Co-Founder

Benjamin Wolin, Chief Executive Officer & Co-Founder

Session: Inter-generational CEO Summit Panel

Features Ingo Elfering, Indivior, Chief Information Officer

Ingo Elfering, Indivior, Chief Information Officer

Session: Navigating Pharma Internal

Features Michele Polz, Biogen Idec, Head, Patient Insights, Global Commercial Strategy

Michele Polz, Biogen Idec, Head, Patient Insights, Global Commercial Strategy

Session: Rapid innovation and Big Pharma


Does a health psychology approach hold the key to Rx adherence? In MM&M's latest Leadership Exchange Uncut eBook, industry stakeholders from the payer, provider, academic and pharma realms explore the "why" behind medicine taking. Access here.